An investigational polymerase chain reaction (PCR) test that detects the presence of a viral gene in Lyme disease–causing bacteria can distinguish between early and late infection, according to the ...
GA, UNITED STATES, June 4, 2026 /EINPresswire.com/ — As antibiotic resistance threatens to outpace available treatments, bacteriophage therapy has re-emerged as a ...
Lyon (France) – November 18, 2024, at 06:00 p.m. CET – PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), hereafter "The Company" or PHAXIAM, a biopharmaceutical company developing innovative ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Mayo Clinic and Adaptive Phage Therapeutics (APT) today announced a collaboration to advance and commercialize a phage susceptibility test (PST) linked exclusively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results